Speaker Profile
MD, PhD, Chief Medical Officer, Delve Bio
Biography
Dr. Miller is a board certified clinical pathologist with expertise in microbiology and infectious disease diagnostics. He has specialized in development and validation of molecular diagnostic testing for pathogen detection and characterization, with a focus on the application of broadspectrum identification methods to patient diagnostics. Much of his career has involved use of next generation sequencing of microorganisms to diagnose infections and enable detailed strain characterization by genome analysis tools, with a goal to improve clinical testing and public health monitoring.
Clinical Dx Showcase:
Delve Bio
As exclusive licensee of University of California San Francisco’s (UCSF) metagenomic sequencing (mNGS) technology, Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
